Upgrade to SI Premium - Free Trial

UBS Upgrades ResMed (RMD) to Buy

October 25, 2013 8:59 AM
UBS upgraded ResMed (NYSE: RMD) from Neutral to Buy.

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Upgrades

Next Articles